Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Trial of Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

NCT00928525 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT00928525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00928525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Trial of Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
Lead sponsor
Italian Sarcoma Group
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
December 31, 2018
Enrollment
35 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

advanced chondrosarcoma, advanced desmoid tumor